Credit Suisse Ag Soma Logic, Inc. Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$1.76 - $2.83 $63,659 - $102,361	36,170 Added 34.67%	140,493 $355,000
Q3 2023 Nov 13, 2023	SELL	$1.99 - $2.45 $16,982 - $20,908	-8,534 Reduced 7.56%	104,323 $249,000
Q2 2023 Aug 11, 2023	BUY	$2.1 - $3.36 $17,411 - $27,857	8,291 Added 7.93%	112,857 $260,000
Q1 2023 May 10, 2023	BUY	$2.13 - $3.6 $24,149 - $40,816	11,338 Added 12.16%	104,566 $266,000
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $321 - $544	157 Added 0.17%	93,228 $234,000
Q3 2022 Nov 10, 2022	BUY	$0.63 - $5.47 $496 - $4,310	788 Added 0.85%	93,071 $270,000
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $317,841 - $614,841	74,436 Added 417.08%	92,283 $418,000
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $126,178 - $207,382	17,847 New	17,847 $143,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.